Skip navigation



IONTAS Celebrates 5 Years of Antibody Discovery

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, is celebrating its fifth anniversary. To mark the occasion, the Company held an anniversary party at King’s College, Cambridge, on 30th June 2018, with drinks, dinner and live music. More »
02 July 2018

TTP Plc and Cubed Laboratories Announce Successful Completion of Product Development Project

TTP Plc (TTP), a leading independent technology and product development company, and Cubed Laboratories (Cubed), a developer of rapid, DNA-based molecular diagnostic devices and test kits, today announced the successful completion of a project to develop Cubed’s core product, the NESDEP portable laboratory for pathogen detection. More »
02 July 2018

Breath Biopsy Platform Scoops the UK’s most Prestigious Award for Engineering Innovation

Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has announced the team behind the Company’s unique Breath Biopsy® platform has been named the winner of the MacRobert Award 2018 by the Royal Academy of Engineering. More »
28 June 2018

BioIVT to Focus on the Application of In Vitro Heptocyte Models in Toxicology Research at the North American ISSX Meeting

Research using BioIVT’s TRANSPORTER CERTIFIED™ hepatocytes in sandwich culture and HEPATOPAC® technology in vitro liver models will be presented. More »
28 June 2018

Kymab Announces Clinical Trial Agreement, for Testing in Multiple Solid Tumours

Kymab Group Ltd (“Kymab”), a clinical stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced a clinical trial agreement with F. Hoffmann-La Roche Ltd (“Roche”). More »
28 June 2018

Silence Therapeutics Strengthens Board and Leadership Team

Silence Therapeutics plc, AIM:SLN (“Silence” or “the Company”) a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces today the appointment of Dave Lemus to its Board as Non-Executive Director effective immediately. Silence also announces the appointment of Richard Jenkins as Head of Clinical Development. More »
25 June 2018

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage. More »
25 June 2018

Five major UK Life Sciences Membership Associations team up to lobby parliament regarding Entrepreneurs’ Relief

OBN, OneNucleus, BioNow, Medilink Midlands and MediWales, major not-for-profit life sciences membership organisations in the UK, which together represent around 2,000 active life sciences companies, have sent an open letter on Friday 22 June to the Chancellor of the Exchequer the Rt Hon Philip Hammond, MP in regard to the recently proposed changes to Entrepreneurs’ Relief. More »
25 June 2018

Darren Beckinsale Joins The RSA Group as Consultant

The RSA Group, a leading Life Sciences executive search firm, announced today that Darren Beckinsale has joined the firm as a Consultant. Darren will form part of the firm’s fast-growing Interims Practice. More »
25 June 2018

Arecor Announces Superfast Insulin Data Presentations

Arecor announces superfast insulin data presentations at the American Diabetes Association 78th Scientific Sessions. More »
22 June 2018

<< Previous   Page 2 of 43   Next >>